Table 1 Testicular cancer patient characteristics and clinicopathologic features for the full cohort and among different racial groups
From: Racial differences in testicular cancer in the United States: descriptive epidemiology
|  | Total (n = 56,898) | NHW (n = 42,556) | HW (n = 9282) | Black (n = 1602) | API (n = 2607) | P-value |
|---|---|---|---|---|---|---|
Marital status |  |  |  |  |  | < 0.001 |
 Single | 23,707(42.2) | 16,341(38.4) | 5121(55.2) | 877(54.7) | 1298(49.8) |  |
 Married | 26,663(47.5) | 21,624(50.8) | 3383(36.5) | 516(32.2) | 1080(41.4) |  |
 Separated/D/W | 3518(6.3) | 2850(6.7) | 425(4.6) | 118(7.4) | 118(4.5) |  |
Age group |  |  |  |  |  | < 0.001 |
 0–39 | 38,408(68.4) | 27,663(65.0) | 7731(83.3) | 1051(65.6) | 1846(70.8) |  |
 40–64 | 15,309(27.2) | 12,293(30.1) | 1374(14.8) | 483(30.1) | 609(23.4) |  |
 65+ | 2475(4.4) | 1766(4.8) | 177(1.9) | 68(4.2) | 152(5.8) |  |
Age at diagnosis | 35.9 ± 17.2 | 37.0 ± 15.1 | 30.7 ± 15.3 | 36.2 ± 14.2 | 35.1 ± 14.8 | < 0.001 |
Survival time | 109.0 | 124.0 | 67.0 | 84.5 | 85.0 | < 0.001 |
(months) | (41.0,191.0) | (51.0,214.0) | (21.0,135.0) | (27.5161.0) | (29.0,174.0) | Â |
Subtype |  |  |  |  |  | < 0.001 |
 Seminomas | 29,423(52.4) | 23,018(54.1) | 4165(44.9) | 835(52.1) | 1321(50.7) |  |
 Teratoma | 13,947(24.8) | 9945(23.4) | 3013(32.5) | 320(20.0) | 635(24.4) |  |
 ECs | 6447(11.5) | 5079(11.9) | 977(10.5) | 121(7.6) | 256(9.8) |  |
 Non-seminomas | 1521(2.7) | 1010(2.4) | 366(3.9) | 60(3.8) | 81(3.1) |  |
 Others | 4854(8.6) | 3504(8.) | 761(8.2) | 266(16.6) | 314(12.0) |  |
Location |  |  |  |  |  | < 0.001 |
 Undescended testis | 969(1.7) | 611(1.4) | 208(2.2) | 61(3.8) | 88(3.4) |  |
 Descended testis | 19,451(34.6) | 13,699(32.2) | 4378(47.2) | 448(28.0) | 891(34.2) |  |
 Testis (NOS) | 35,772(63.7) | 28,246(66.4) | 4696(50.6) | 1093(68.2) | 1628(62.5) |  |
Stage |  |  |  |  |  | < 0.001 |
 In situ | 97(0.2) | 63(0.2) | 22(0.2) | 9(0.5) | 3(0.1) |  |
 Localized | 36,513(65.0) | 28,136(66.2) | 5718(61.6) | 919(57.4) | 1638(62.8) |  |
 Regional | 10,173(18.1) | 7671(18.0) | 1751(18.9) | 315(19.7) | 415(15.9) |  |
 Distant | 6472(11.5) | 4388(10.3) | 1486(16.0) | 244(15.3) | 340(13.0) |  |
Tumor size (mm) | 45.7 ± 36.3 | 42.3 ± 33.2 | 52.4 ± 41.2 | 57.4 ± 44.0 | 53.0 ± 42.5 | < 0.001 |
Regional nodes |  |  |  |  |  | < 0.001 |
 All nodes negative | 7693(14.4) | 5948(14.6) | 1124(13.1) | 253(16.8) | 360(14.8) |  |
≥1 nodes positive | 45,676(85.6) | 34,797(85.4) | 7436(86.9) | 1253(83.2) | 2072(85.2) |  |
Treatment |  |  |  |  |  | < 0.001 |
 Surgery | 22,848(40.2) | 16,710(39.3) | 3914(42.2) | 638(39.8) | 1021(39.2) |  |
 CS | 15,542(27.3) | 11,152(26.2) | 3073(33.1) | 452(28.2) | 741(28.4) |  |
 RS | 15,176(26.7) | 12,382(29.1) | 1693(18.2) | 352(22.0) | 637(24.4) |  |
 CRS | 1336(2.4) | 970(2.3) | 214(2.3) | 54(3.4) | 94(3.6) |  |
 Chemotherapy | 964(1.7) | 615(1.5) | 236(2.5) | 53(3.3) | 56(2.2) |  |
 No treatment | 790(1.4) | 552(1.3) | 114(1.2) | 42(2.6) | 44(1.7) |  |
 Radiation | 119(0.2) | 97(0.2) | 11(0.1) | 3(0.2) | 4(0.2) |  |
 CR | 123(0.2) | 78(0.2) | 27(0.3) | 8(0.5) | 10(0.4) |  |